ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+1.8%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$326M
AUM Growth
+$326M
(-7.8%)
Cap. Flow
-$28.9M
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
109
New
17
Increased
26
Reduced
40
Closed
25
Top Buys
| 1 |
Sabra Healthcare REIT
SBRA
|
$12.2M |
| 2 |
Danaher
DHR
|
$11.8M |
| 3 |
Pediatrix Medical
MD
|
$7.61M |
| 4 |
Johnson & Johnson
JNJ
|
$7.35M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$6.25M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$8.29M |
| 2 |
UnitedHealth
UNH
|
$6.6M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$6.29M |
| 4 |
iRhythm Technologies
IRTC
|
$6.29M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.24M |
Sector Composition
| 1 | Healthcare | 83.72% |
| 2 | Real Estate | 3.74% |
| 3 | Financials | 3% |
| 4 | Industrials | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
76
DELISTED
Immunogen Inc
IMGN
| $601K | 0.18% | 78,500 -26,000 | -25% | -$199K |
|
77
SPDR S&P Biotech ETF
XBI
$5.07B
| $545K | 0.17% | 6,300 +3,000 | +91% | +$260K |
|
78
Centene
CNC
$14.3B
| $523K | 0.16% | 5,400 -21,676 | -80% | -$2.1M |
|
|
LCI
79
DELISTED
Lannett Company, Inc.
LCI
| $517K | 0.16% | +28,000 | New | +$517K |
|
|
RDUS
80
DELISTED
Radius Health, Inc.
RDUS
| $405K | 0.12% | 10,500 -12,900 | -55% | -$498K |
|
|
LUMO
81
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $367K | 0.11% | 36,100 -48,498 | -57% | -$493K |
|
82
Teva Pharmaceuticals
TEVA
$21.1B
| $319K | 0.1% | 18,133 -44,700 | -71% | -$786K |
|
|
CBIO
83
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $246K | 0.07% | 17,607 -14,300 | -45% | -$200K |
|
84
Agilent Technologies
A
$35.7B
| – | – | -8,600 | Closed | -$510K |
|
85
Brookdale Senior Living
BKD
$1.83B
| – | – | -126,500 | Closed | -$1.86M |
|
86
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -9,300 | Closed | -$845K |
|
87
CONMED
CNMD
$1.68B
| – | – | -18,700 | Closed | -$953K |
|
88
Charles River Laboratories
CRL
$8.04B
| – | – | -28,248 | Closed | -$2.86M |
|
89
Exelixis
EXEL
$10.1B
| – | – | -15,870 | Closed | -$391K |
|
90
Amicus Therapeutics
FOLD
$2.34B
| – | – | -118,800 | Closed | -$1.2M |
|
91
Illumina
ILMN
$15.8B
| – | – | -8,800 | Closed | -$1.53M |
|
92
Labcorp
LH
$23.1B
| – | – | -7,212 | Closed | -$1.11M |
|
93
Eli Lilly
LLY
$657B
| – | – | -9,600 | Closed | -$790K |
|
94
Orthofix Medical
OFIX
$592M
| – | – | -30,400 | Closed | -$1.41M |
|
95
Regenxbio
RGNX
$451M
| – | – | -36,000 | Closed | -$711K |
|
96
Revvity
RVTY
$10.5B
| – | – | -24,400 | Closed | -$1.66M |
|
|
NUVA
97
DELISTED
NuVasive, Inc.
NUVA
| – | – | -27,800 | Closed | -$2.14M |
|
|
LMNX
98
DELISTED
Luminex Corp
LMNX
| – | – | -12,600 | Closed | -$266K |
|
|
MNK
99
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – | -39,575 | Closed | -$1.77M |
|
|
AKRX
100
DELISTED
Akorn, Inc.
AKRX
| – | – | -22,400 | Closed | -$751K |
|